×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Novo likely to launch survey on young diabetics in Nov

Novo likely to launch survey on young diabetics in Nov
Comment E-mail Print Share
First Published: Mon, Oct 27 2008. 11 07 PM IST

Finding reasons: A technician at Novo Nordisk. The company plans a nationwide survey to understand the attitudes towards diabetes. John McConnico / Bloomberg
Finding reasons: A technician at Novo Nordisk. The company plans a nationwide survey to understand the attitudes towards diabetes. John McConnico / Bloomberg
Updated: Mon, Oct 27 2008. 11 07 PM IST
Mumbai: The world’s largest insulin maker by sales, Novo Nordisk A/S, is set to launch India’s first survey on young diabetics in November.
Finding reasons: A technician at Novo Nordisk. The company plans a nationwide survey to understand the attitudes towards diabetes. John McConnico / Bloomberg
The initiative, Dawn Youth, is part of a global programme that will explore the attitudes, wishes and needs of young people with, or at risk of, diabetes and their families.
Diabetes is one of the fastest growing diseases in India and there are at least a dozen drug makers, foreign and local, focusing on this market. Pfizer Inc., Eli Lilly and Co., Wockhardt Ltd and Biocon Ltd, for instance, have lined up new launches in the oral drug and insulin market.
Collecting data on young diabetics who have the disease but have not been exposed to any medical investigation will be the first phase of the Novo programme. The current Indian diabetic population is estimated to be about 40.5 million, according to statistics available from hospitals and medical practitioners based on reported cases, and compiled by International Diabetes Federation or IDF. This is likely to be double by 2015.
“Since diabetes is a disease which a patient may not be even aware of at the young (age), (it) often surfaces with other complications triggered by early diabetes. So detecting the disease or collection of this data is very important to manage this disease in countries like India,” says Andre M.J. Gomes, head of corporate communications at Novo Nordisk India Pvt. Ltd, the Indian arm of the Danish company.
The company plans a nationwide survey to understand the social stigma linked to diabetes and the lifestyle and food habits leading to the disease. It will also conduct free blood sugar check-up camps.
According to Gomes, the disease becomes complicated by the time a patient reaches 30-35 years, and critical socio-psychological issues tend to emerge.
“Analysing the second aspect is more important while managing the disease early,” he added.
Novo had started an online education programme three years ago but Dawn Youth was launched worldwide in November in collaboration with IDF and International Society for Paediatric and Adolescent Diabetics. It has covered at least 20 countries, including Brazil, Japan, South Africa, the US, UK, Denmark, Italy, Netherlands and Germany.
Comment E-mail Print Share
First Published: Mon, Oct 27 2008. 11 07 PM IST